Northern Trust Corp Tempest Therapeutics, Inc. Transaction History
Northern Trust Corp
- $690 Billion
- Q4 2024
A detailed history of Northern Trust Corp transactions in Tempest Therapeutics, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 67,815 shares of TPST stock, worth $54,930. This represents 0.0% of its overall portfolio holdings.
Number of Shares
67,815
Previous 20,354
233.18%
Holding current value
$54,930
Previous $28,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding TPST
# of Institutions
39Shares Held
6.35MCall Options Held
34.9KPut Options Held
148K-
Versant Venture Management, LLC San Francisco, CA3.51MShares$2.84 Million4.35% of portfolio
-
Black Rock Inc. New York, NY550KShares$445,6950.0% of portfolio
-
Jane Street Group, LLC New York, NY493KShares$399,4060.0% of portfolio
-
Geode Capital Management, LLC Boston, MA354KShares$286,9630.0% of portfolio
-
Ubs Group Ag196KShares$158,4970.0% of portfolio
About Tempest Therapeutics, Inc.
- Ticker TPST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,418,900
- Market Cap $8.44M
- Description
- Tempest Therapeutics Inc., a clinical-stage oncology company, engages in developing small molecule therapeutics to treat cancer. The company's two clinical programs are TPST-1495, a dual antagonist of EP2 and EP4, receptors of prostaglandin E2, and is currently in a Phase 1 trial in solid tumors; and TPST-1120, a selective antagonist of peroxiso...